We are live on
!
Find out more
OWP
Obermeyer Wealth Partners Portfolio holdings
AUM
$2.44B
1-Year Est. Return
24.34%
This Fund
S&P 500
This Quarter
Est. Return
-1.14%
1 Year Est. Return
+24.34%
3 Year Est. Return
+80.9%
5 Year Est. Return
+91.9%
10 Year Est. Return
+492.93%
AUM
$1.01B
AUM Growth
-$74M
(-6.9%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-19.75%
Top 10 Holdings %
Top 10 Hldgs %
47.44%
Holding
133
New
10
Increased
20
Reduced
65
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$32.7M |
| 2 |
Akamai
AKAM
|
+$24.5M |
| 3 |
WBT
Welbilt, Inc.
WBT
|
+$21.3M |
| 4 |
Crown Castle
CCI
|
+$1.44M |
| 5 |
AMRI
Albany Molecular Research Inc
AMRI
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$149M |
| 2 |
General Motors
GM
|
+$43.1M |
| 3 |
Brookfield
BN
|
+$16.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$13M |
| 5 |
Analog Devices
ADI
|
+$9.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.29% |
| 2 | Financials | 17.85% |
| 3 | Technology | 10.58% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $88.5M | 8.81% |
897,658
-125,650
| -12% | -$13M |
|
2
Brookdale Senior Living
BKD
$3.55B
| $55.8M | 5.55% |
3,612,679
-103,170
| -3% | -$1.8M |
|
3
McDonald's
MCD
$193B
| $53.1M | 5.28% |
441,223
-12,325
| -3% | -$1.54M |
|
4
Alphabet (Google) Class C
GOOG
$4.11T
| $48.1M | 4.79% |
1,390,840
-49,600
| -3% | -$1.78M |
|
5
Mastercard
MA
$498B
| $45.7M | 4.55% |
519,469
-36,149
| -7% | -$3.45M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $41.8M | 4.16% |
180,735
-3,600
| -2% | -$830K |
|
7
Intel
INTC
$413B
| $41.5M | 4.13% |
1,266,468
-91,020
| -7% | -$2.85M |
|
8
UnitedHealth
UNH
$382B
| $34.3M | 3.41% |
243,069
-22,325
| -8% | -$2.98M |
|
9
Goldman Sachs
GS
$289B
| $34.1M | 3.39% |
229,401
-4,102
| -2% | -$640K |
|
10
CBRE Group
CBRE
$43.3B
| $33.8M | 3.36% |
1,276,599
-55,070
| -4% | -$1.61M |
|
|
11
Gilead Sciences
GILD
$165B
| $30.7M | 3.06% |
+368,354
| New | +$32.7M |
|
12
NXP Semiconductors
NXPI
$60.8B
| $30.4M | 3.03% |
388,202
-6,252
| -2% | -$536K |
|
13
Robert Half
RHI
$4.11B
| $30.2M | 3% |
791,377
-1,718
| -0.2% | -$70.2K |
|
14
Bank of America
BAC
$429B
| $30.1M | 2.99% |
2,266,815
-151,834
| -6% | -$2.13M |
|
|
CTRA
15
DELISTED
Coterra Energy
CTRA
| $29.5M | 2.93% |
1,145,960
-12,772
| -1% | -$306K |
|
|
16
Akamai
AKAM
$15.6B
| $26.1M | 2.59% |
+465,905
| New | +$24.5M |
|
17
MetLife
MET
$62.4B
| $25M | 2.49% |
703,873
-95,068
| -12% | -$3.71M |
|
|
AMRI
18
DELISTED
Albany Molecular Research Inc
AMRI
| $24M | 2.39% |
1,788,043
+39,893
| +2% | +$582K |
|
|
WBT
19
DELISTED
Welbilt, Inc.
WBT
| $23.6M | 2.35% |
+1,339,781
| New | +$21.3M |
|
20
Eaton
ETN
$141B
| $22.9M | 2.28% |
383,752
-36,021
| -9% | -$2.21M |
|
|
21
Berkshire Hathaway Class B
BRK.B
$1.1T
| $22.1M | 2.2% |
152,947
-3,827
| -2% | -$547K |
|
22
Lowe's Companies
LOW
$121B
| $18.7M | 1.86% |
236,636
-36,173
| -13% | -$2.8M |
|
23
Wells Fargo
WFC
$254B
| $17.4M | 1.73% |
367,698
-22,585
| -6% | -$1.1M |
|
24
Medtronic
MDT
$112B
| $16.6M | 1.66% |
191,790
-98,937
| -34% | -$8M |
|
25
Carnival Corporation Ltd
CCL
$38.1B
| $14.3M | 1.42% |
323,512
-21,512
| -6% | -$1.05M |
|
Similar funds
QT
TMC
GWM
KFA
BW
M
BBA
SCM
Obermeyer Wealth Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Obermeyer Wealth Partners held 133 positions worth $1.01B, down 6.9% from $1.08B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Obermeyer Wealth Partners withdrew a net $198M in Q2 2016, closing 5 positions and reducing 65 holdings. Its most notable exit was Brookfield, an estimated $16.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Financials and Technology.
Against the trend, Obermeyer Wealth Partners opened a new position in Gilead Sciences worth $30.7M.
- Obermeyer Wealth Partners's largest Q2 2016 buy was Gilead Sciences: 368,354 shares worth $30.7M.
- Obermeyer Wealth Partners added most to Crown Castle in Q2 2016, an estimated $1.44M increase.
- Obermeyer Wealth Partners's biggest Q2 2016 reduction was Berkshire Hathaway Class A, cutting an estimated $149M.
- Obermeyer Wealth Partners fully exited Brookfield in Q2 2016, selling an estimated $16.2M.
- Obermeyer Wealth Partners's ten largest holdings make up 47% of its $1.01B portfolio in Q2 2016.
- Obermeyer Wealth Partners opened 10 new positions and closed 5 in Q2 2016.
- Obermeyer Wealth Partners's portfolio value fell 6.9% quarter-over-quarter to $1.01B.
Based on Obermeyer Wealth Partners's 13F filing for Q2 2016, filed 3 Aug 2016.